Lataa...
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
Josep Darbà,1 Lisette Kaskens,2 Francesc Sorio Vilela,3 Mickael Lothgren4 1Department of Economics, Universitat de Barcelona, 2BCN Health Economics and Outcomes Research SL, 3Amgen SA, Barcelona, Spain; 4Amgen (Europe) GmbH, Zug, Switzerland Background: The objective of this study was to...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2015-02-01
|
| Sarja: | ClinicoEconomics and Outcomes Research |
| Linkit: | http://www.dovepress.com/cost-utility-of-denosumab-for-the-treatment-of-postmenopausal-osteopor-peer-reviewed-article-CEOR |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|